PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,838,000 | -38.0% | 336,223 | 0.0% | 0.06% | -15.3% |
| Q1 2022 | $4,576,000 | -30.8% | 336,223 | 0.0% | 0.07% | -15.3% |
| Q4 2021 | $6,614,000 | -65.7% | 336,223 | -44.0% | 0.08% | -66.5% |
| Q3 2021 | $19,260,000 | -5.2% | 600,000 | 0.0% | 0.25% | -7.0% |
| Q2 2021 | $20,310,000 | -9.9% | 600,000 | 0.0% | 0.27% | -18.3% |
| Q1 2021 | $22,536,000 | +13.1% | 600,000 | 0.0% | 0.33% | +9.2% |
| Q4 2020 | $19,932,000 | +20.8% | 600,000 | +33.3% | 0.31% | -5.3% |
| Q3 2020 | $16,502,000 | +11.4% | 450,000 | 0.0% | 0.32% | +0.3% |
| Q2 2020 | $14,809,000 | +27.5% | 450,000 | 0.0% | 0.32% | -14.4% |
| Q1 2020 | $11,619,000 | -17.1% | 450,000 | 0.0% | 0.38% | -4.8% |
| Q4 2019 | $14,013,000 | – | 450,000 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $28,143,000 | 7.62% |
| Frazier Life Sciences Management, L.P. | 5,827,415 | $79,311,000 | 6.76% |
| Abingworth LLP | 1,435,106 | $19,503,000 | 5.53% |
| Penn Mutual Asset Management, LLC | 86,940 | $1,183,000 | 1.37% |
| MPM BioImpact LLC | 193,326 | $2,631,000 | 0.71% |
| Avidity Partners Management LP | 1,946,000 | $26,485,000 | 0.55% |
| StepStone Group LP | 422,085 | $5,745,000 | 0.43% |
| Rhenman & Partners Asset Management AB | 235,210 | $3,201,000 | 0.32% |
| Summit Rock Advisors, LP | 34,100 | $464,000 | 0.28% |
| Parkman Healthcare Partners LLC | 65,553 | $892,000 | 0.26% |